David Klonoff to Betacoronavirus
This is a "connection" page, showing publications David Klonoff has written about Betacoronavirus.
Connection Strength
0.184
-
Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries. Eur J Med Res. 2020 Nov 10; 25(1):56.
Score: 0.039
-
The Coronavirus 2019 Pandemic and Diabetes: An International Perspective. J Diabetes Sci Technol. 2020 07; 14(4):703-704.
Score: 0.038
-
Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock. J Diabetes Sci Technol. 2020 Jul; 14(4):741-742.
Score: 0.038
-
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity. Metabolism. 2020 07; 108:154224.
Score: 0.037
-
Hospital Diabetes Meeting 2020. J Diabetes Sci Technol. 2020 09; 14(5):928-944.
Score: 0.010
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation. Eur J Endocrinol. 2020 Aug; 183(2):G67-G77.
Score: 0.010
-
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020 Jul; 14(4):813-821.
Score: 0.009
-
Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol. 2020 Jul; 14(4):822-832.
Score: 0.002
-
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. Eur Rev Med Pharmacol Sci. 2020 04; 24(8):4539-4547.
Score: 0.002